Joanna Wiensch
Stock Analyst at Citigroup
(2.57)
# 2,249
Out of 4,761 analysts
29
Total ratings
70%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Joanna Wiensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Upgrades: Buy | $255 → $275 | $227.43 | +20.92% | 5 | Oct 1, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $119 → $127 | $134.92 | -5.87% | 8 | Aug 22, 2024 | |
| NVRO Nevro | Downgrades: Neutral | $40 | $5.73 | +598.08% | 1 | Jan 17, 2023 | |
| DXCM DexCom | Maintains: Buy | $83 → $90 | $88.78 | +1.66% | 2 | Apr 29, 2020 | |
| COO The Cooper Companies | Maintains: Neutral | $90 → $80 | $88.48 | -10.15% | 2 | Mar 27, 2020 | |
| IRTC iRhythm Technologies | Initiates: Buy | $120 | $119.44 | +0.47% | 1 | Mar 5, 2020 | |
| PEN Penumbra | Initiates: Buy | $200 | $291.68 | -31.43% | 1 | Mar 5, 2020 | |
| GKOS Glaukos | Initiates: Sell | $40 | $125.88 | -68.22% | 1 | Mar 5, 2020 | |
| ZBH Zimmer Biomet Holdings | Initiates: Buy | $168 | $104.83 | +60.26% | 1 | Mar 5, 2020 | |
| ALC Alcon | Initiates: Neutral | $63 | $90.31 | -30.24% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $235 | $382.78 | -38.61% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $220 | $282.80 | -22.21% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $84 | $73.30 | +14.60% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $94 | $33.82 | +177.94% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $163 | $162.30 | +0.43% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $89.94 | +37.87% | 1 | Mar 5, 2020 |
Becton, Dickinson and Company
Oct 1, 2024
Upgrades: Buy
Price Target: $255 → $275
Current: $227.43
Upside: +20.92%
Abbott Laboratories
Aug 22, 2024
Maintains: Buy
Price Target: $119 → $127
Current: $134.92
Upside: -5.87%
Nevro
Jan 17, 2023
Downgrades: Neutral
Price Target: $40
Current: $5.73
Upside: +598.08%
DexCom
Apr 29, 2020
Maintains: Buy
Price Target: $83 → $90
Current: $88.78
Upside: +1.66%
The Cooper Companies
Mar 27, 2020
Maintains: Neutral
Price Target: $90 → $80
Current: $88.48
Upside: -10.15%
iRhythm Technologies
Mar 5, 2020
Initiates: Buy
Price Target: $120
Current: $119.44
Upside: +0.47%
Penumbra
Mar 5, 2020
Initiates: Buy
Price Target: $200
Current: $291.68
Upside: -31.43%
Glaukos
Mar 5, 2020
Initiates: Sell
Price Target: $40
Current: $125.88
Upside: -68.22%
Zimmer Biomet Holdings
Mar 5, 2020
Initiates: Buy
Price Target: $168
Current: $104.83
Upside: +60.26%
Alcon
Mar 5, 2020
Initiates: Neutral
Price Target: $63
Current: $90.31
Upside: -30.24%
Mar 5, 2020
Initiates: Buy
Price Target: $235
Current: $382.78
Upside: -38.61%
Mar 5, 2020
Initiates: Buy
Price Target: $220
Current: $282.80
Upside: -22.21%
Mar 5, 2020
Initiates: Buy
Price Target: $84
Current: $73.30
Upside: +14.60%
Mar 5, 2020
Initiates: Neutral
Price Target: $94
Current: $33.82
Upside: +177.94%
Mar 5, 2020
Initiates: Buy
Price Target: $163
Current: $162.30
Upside: +0.43%
Mar 5, 2020
Initiates: Buy
Price Target: $124
Current: $89.94
Upside: +37.87%